Search

Search Constraints

You searched for: Author/Creator Seidel, Sabine

Search Results

1. ACTR-53. MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL. (11th November 2019)

2. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma. Issue 3 (6th August 2015)

7. MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial. Issue 7 (10th November 2020)

9. Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma. (8th December 2020)